SMMT
XNASSummit Therapeutics Inc. Common Stock
Basic Materials · Pharmaceutical Preparations
$17.54
+0.00 (+0.00%)
15-min delayed
Drag to pan · Scroll to zoom · Hover for OHLC
Snapshot
Loading metrics…
About Summit Therapeutics Inc. Common Stock
Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its CDI (Clostridiodes difficile infection) product candidate is ridinilazole, an orally administered small molecule antibiotic. It has two geographical segments: the United States and the United Kingdom.
Employees
265
Country
US
IPO Date
2015-03-05
Recent News
Summit Therapeutics: More Uncertainty Heading Into The ASCO Plenary
SeekingAlpha · 1d ago
HC Wainwright & Co. Maintains Buy on Summit Therapeutics, Lowers Price Target to $23
Benzinga · 2d ago
What's going on in today's session
ChartMill · 4d ago
Which stocks are moving on Friday?
ChartMill · 4d ago
Crude Oil Down 3%; Chevron Posts Mixed Q1 Results
Benzinga · 4d ago
Let's uncover which stocks are experiencing notable gaps during today's session.
ChartMill · 4d ago
Nasdaq Jumps Over 1%; Exxon Mobil Posts Upbeat Revenue
Benzinga · 4d ago
Piper Sandler Maintains Neutral on Summit Therapeutics, Lowers Price Target to $16
Benzinga · 4d ago
Analyst Ratings
Loading…
Financials
Loading SEC filings…
Insider Activity
Loading filings…
Related Stocks
Loading peers…
Data is 15-minute delayed, for informational purposes only. Not investment advice. Prices via Massive.com consolidated feed. Fundamentals via FinancialModelingPrep. News via Finnhub.